61325-71-1 Usage
Description
2-ethyl-4-(4-Methyl-1-piperazinyl)10H-Thieno[2,3-b][1,5]benzodiazepine is a benzodiazepine derivative featuring a thieno ring structure, with an ethyl and a methyl-piperazinyl group attached to the benzodiazepine core. 2-ethyl-4-(4-Methyl-1-piperazinyl)10H-Thieno[2,3-b][1,5]benzodiazepine belongs to a class of psychoactive drugs that are typically used to treat anxiety, insomnia, and other conditions related to the central nervous system. Its unique chemical structure suggests potential sedative, muscle relaxant, and anxiolytic effects, although further research is needed to confirm its specific pharmacological properties and therapeutic applications.
Uses
Used in Pharmaceutical Industry:
2-ethyl-4-(4-Methyl-1-piperazinyl)10H-Thieno[2,3-b][1,5]benzodiazepine is used as a potential therapeutic agent for the treatment of anxiety disorders due to its benzodiazepine core and the presence of a methyl-piperazinyl group, which may contribute to its anxiolytic properties.
Used in Sleep Aid Formulations:
In the pharmaceutical industry, 2-ethyl-4-(4-Methyl-1-piperazinyl)10H-Thieno[2,3-b][1,5]benzodiazepine may be utilized as an ingredient in sleep aid formulations, given its potential sedative effects, which could help alleviate insomnia and other sleep-related issues.
Used in Muscle Relaxant Formulations:
2-ethyl-4-(4-Methyl-1-piperazinyl)10H-Thieno[2,3-b][1,5]benzodiazepine may also be used in muscle relaxant formulations, potentially providing relief from muscle spasms and tension, due to its structural similarity to other benzodiazepines known for their muscle-relaxing properties.
Check Digit Verification of cas no
The CAS Registry Mumber 61325-71-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,3,2 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 61325-71:
(7*6)+(6*1)+(5*3)+(4*2)+(3*5)+(2*7)+(1*1)=101
101 % 10 = 1
So 61325-71-1 is a valid CAS Registry Number.
61325-71-1Relevant articles and documents
COMPOUND FOR THE TREATMENT OF CNS DISORDERS
-
Page 8-10, (2008/06/13)
The present invention relates to the compound 2-ethyl-10-(4-methyl-1-piperazinyl)-4H-thieno[2,3-b][1,5]benzodiazepine and its use as is or in substantially pure form in the treatment of CNS disorders including schizophrenia and bipolar disorder. The compound is prepared by reacting a substituted thiophene compound with 2-fluoronitrobenzene to form, after ring closure and reaction with N-methylpiperazine, the title compound. The compound is then purified to substantially pure form and is useful as an antipsychotic. The compound may also be combined with other active ingredients including HMG CoA reductase inhibitors such as lovastatin or simvastatin and/or antidepressants such as fluxoetine or other SSRIs to form medically useful combination products useful in treating psychotic conditions and depression while also preventing any rise beyond the normal range of cholesterol levels in any subset of patients that might develop such a condition.
